Literature DB >> 15815185

Quality of life 5 or more years post-autologous hematopoietic stem cell transplant.

Katherine L Byar1, June E Eilers, Suzanne L Nuss.   

Abstract

This cross-sectional study used a mailed survey to evaluate the quality of life (QOL) of individuals at least 5 years post-autologous stem cell transplant and to determine instrument preference. Instruments selected were the Medical Outcomes Study-Short Form (MOS-SF-36) as the generic measure and the City of Hope-Quality of Life-Bone Marrow Transplant (COH-BMT) and the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) as transplant-specific measures. Subjects received the MOS-SF-36 and were randomized to receive (1) COH-BMT, (2) FACT-BMT, or (3) COH-BMT and FACT-BMT. Ninety-two subjects returned completed forms, for a 56% response rate. A study-specific form indicated subjects preferred the BMT-specific instruments. The health of the majority of subjects (85%) was similar to or somewhat better than what it was the previous year. Their MOS-SF-36 scores for physical functioning, role-physical, bodily pain, and general health subscales were lower than the values for the general population, but those for the other subscales were not significantly different. When compared to the data reported by Hann and colleagues for posttransplant in breast cancer, study subjects scored significantly lower on all scales except General Health and Mental Health. COH-BMT scores compared with those reported by Whedon and Ferrel (Semin Oncol Nurs. 1994;10:42-57) were higher for Physical Well-Being, Spiritual Well-Being, and Global QOL. FACT-BMT results compared with those reported by McQuellen et al (Bone Marrow Transplant. 1997;19:357-368) showed that Physical, Social/Family, Emotional, and Functional Scores were similar; only BMT scores were significantly different. Research is needed to determine when QOL plateaus and whether instrument preference changes over time. Awareness of long-term effects that affect QOL can guide program revisions and facilitate decisions regarding the need for supportive rehabilitative services.

Entities:  

Mesh:

Year:  2005        PMID: 15815185     DOI: 10.1097/00002820-200503000-00010

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  9 in total

1.  Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.

Authors:  Heather S L Jim; Brent Small; Sheri Hartman; Jamie Franzen; Shannon Millay; Kristin Phillips; Paul B Jacobsen; Margaret Booth-Jones; Joseph Pidala
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

2.  Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics.

Authors:  Marcia Grant; Liz Cooke; Anna Cathy Williams; Smita Bhatia; Leslie Popplewell; Gwen Uman; Stephen Forman
Journal:  Support Care Cancer       Date:  2012-02-09       Impact factor: 3.603

Review 3.  The Role of Spirituality in Patients Undergoing Hematopoietic Stem Cell Transplantation: a Systematic Mixed Studies Review.

Authors:  Li-Yuan Zheng; Hua Yuan; Zi-Jun Zhou; Bao-Xing Guan; Ping Zhang; Xiu-Ying Zhang
Journal:  J Gen Intern Med       Date:  2020-02-24       Impact factor: 5.128

4.  Personal financial effects of multiple myeloma and its treatment.

Authors:  Julia A Goodwin; Elizabeth Ann Coleman; Ellen Sullivan; Robin Easley; Paula K McNatt; Nupur Chowdhury; Carol Beth Stewart
Journal:  Cancer Nurs       Date:  2013 Jul-Aug       Impact factor: 2.592

Review 5.  Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.

Authors:  Joseph Pidala; Claudio Anasetti; Heather Jim
Journal:  Br J Haematol       Date:  2009-11-16       Impact factor: 6.998

6.  Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors.

Authors:  Kelly Kenzik; I-Chan Huang; J Douglas Rizzo; Elizabeth Shenkman; John Wingard
Journal:  Support Care Cancer       Date:  2014-09-06       Impact factor: 3.603

Review 7.  Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: a systematic literature review.

Authors:  Sigrid Droste; Annegret Herrmann-Frank; Fueloep Scheibler; Tanja Krones
Journal:  BMC Med Ethics       Date:  2011-04-15       Impact factor: 2.652

8.  The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation.

Authors:  Madeline L O'Sullivan; Rebecca A Shelby; Caroline S Dorfman; Sarah A Kelleher; Hannah M Fisher; Krista A Rowe Nichols; Francis J Keefe; Anthony D Sung; Tamara J Somers
Journal:  Support Care Cancer       Date:  2017-11-09       Impact factor: 3.359

9.  An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial.

Authors:  Tamara J Somers; Sarah A Kelleher; Caroline S Dorfman; Rebecca A Shelby; Hannah M Fisher; Krista Rowe Nichols; Keith M Sullivan; Nelson J Chao; Gregory P Samsa; Amy P Abernethy; Francis J Keefe
Journal:  JMIR Mhealth Uhealth       Date:  2018-03-19       Impact factor: 4.773

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.